109 related articles for article (PubMed ID: 23116743)
21. CD4+ cell count and risk for antiretroviral drug resistance among women using peripartum nevirapine for perinatal HIV prevention.
Dorton BJ; Mulindwa J; Li MS; Chintu NT; Chibwesha CJ; Mbewe F; Frenkel LM; Stringer JS; Chi BH
BJOG; 2011 Mar; 118(4):495-9. PubMed ID: 21199294
[TBL] [Abstract][Full Text] [Related]
22. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
[TBL] [Abstract][Full Text] [Related]
23. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
; de Vincenzi I
Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
[TBL] [Abstract][Full Text] [Related]
24. Increased risk of hepatotoxicity in HIV-infected pregnant women receiving antiretroviral therapy independent of nevirapine exposure.
Ouyang DW; Shapiro DE; Lu M; Brogly SB; French AL; Leighty RM; Thompson B; Tuomala RE; Hershow RC
AIDS; 2009 Nov; 23(18):2425-30. PubMed ID: 19617813
[TBL] [Abstract][Full Text] [Related]
25. [Evaluation of the adverse effects of nevirapine in HIV-infected pregnant women in a South Brazilian University Hospital].
Kondo W; Astori Ade A; Gomes Sel-K; Fernandes Rde B; Sasaki Md; Sbalqueiro RL
Rev Bras Ginecol Obstet; 2008 Jan; 30(1):19-24. PubMed ID: 19142538
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of once-daily combination therapy with didanosine, lamivudine and nevirapine in antiretroviral-naive HIV-infected patients.
Ribera E; Rodríguez-Pardo D; Rubio M; Soler A; Pedrol E; Blanco JL; González A; Crespo M; Falcó V; Ocaña I; Deig E; Miró JM; Pahissa A
Antivir Ther; 2005; 10(5):605-14. PubMed ID: 16152754
[TBL] [Abstract][Full Text] [Related]
27. Risk of side effects associated with the use of nevirapine in treatment-naïve patients, with respect to gender and CD4 cell count.
Knobel H; Guelar A; Montero M; Carmona A; Luque S; Berenguer N; González A
HIV Med; 2008 Jan; 9(1):14-8. PubMed ID: 18199168
[TBL] [Abstract][Full Text] [Related]
28. Standard-dose efavirenz vs. standard-dose nevirapine in antiretroviral regimens among HIV-1 and tuberculosis co-infected patients who received rifampicin.
Manosuthi W; Mankatitham W; Lueangniyomkul A; Chimsuntorn S; Sungkanuparph S
HIV Med; 2008 May; 9(5):294-9. PubMed ID: 18400076
[TBL] [Abstract][Full Text] [Related]
29. Serious toxicity associated with continuous nevirapine-based HAART in pregnancy.
van Schalkwyk JE; Alimenti A; Khoo D; Maan E; Forbes JC; Burdge DR; Gilgoff S; Money DM
BJOG; 2008 Sep; 115(10):1297-302. PubMed ID: 18715416
[TBL] [Abstract][Full Text] [Related]
30. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
[TBL] [Abstract][Full Text] [Related]
31. Long-term assessment of nevirapine-containing highly active antiretroviral therapy in antiretroviral-naive HIV-infected patients: 3-year follow-up of the VIRGO study.
Reliquet V; Allavena C; François-Brunet C; Perré P; Bellein V; Garré M; May T; Souala F; Besnier JM; Raffi F
HIV Med; 2006 Oct; 7(7):431-6. PubMed ID: 16925728
[TBL] [Abstract][Full Text] [Related]
32. Incidence and risk factors of nevirapine-associated severe hepatitis among HIV-infected patients with CD4 cell counts less than 250 cells/microL.
Manosuthi W; Sungkanuparph S; Tansuphaswadikul S; Chottanapund S; Mankatitham W; Chimsuntorn S; Sittibusaya C; Moolasart V; Chaovavanich A
J Med Assoc Thai; 2008 Feb; 91(2):159-65. PubMed ID: 18389979
[TBL] [Abstract][Full Text] [Related]
33. Nevirapine-related adverse events among children switched from efavirenz to nevirapine as compared to children who were started on nevirapine-based antiretroviral therapy directly.
Sanjeeva GN; Sukanya V; Pavithra HB; Dodderi SK; Rewari BB; Govindaraj M; Shivananda S; Premalatha R
AIDS Care; 2015; 27(5):655-9. PubMed ID: 25517472
[TBL] [Abstract][Full Text] [Related]
34. Evolving care of HIV-infected pregnant women in Jamaica--from nevirapine to HAART.
Johnson N; Palmer P; Samuels LA; Morgan O; Onyonyor A; Anderson M; Moore J; Billings C; Harvey KM; Mullings A; McDonald D; Alexander G; Smikle MF; Williams EW; Davis D; Christie CD
West Indian Med J; 2008 Jun; 57(3):216-22. PubMed ID: 19583119
[TBL] [Abstract][Full Text] [Related]
35. Highly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trial.
Chung MH; Kiarie JN; Richardson BA; Lehman DA; Overbaugh J; Kinuthia J; Njiri F; John-Stewart GC
Antivir Ther; 2008; 13(6):799-807. PubMed ID: 18839781
[TBL] [Abstract][Full Text] [Related]
36. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial.
Taha TE; Kumwenda NI; Hoover DR; Fiscus SA; Kafulafula G; Nkhoma C; Nour S; Chen S; Liomba G; Miotti PG; Broadhead RL
JAMA; 2004 Jul; 292(2):202-9. PubMed ID: 15249569
[TBL] [Abstract][Full Text] [Related]
37. Hepatotoxicity during nevirapine-based fixed-dose combination antiretroviral therapy in kampala, Uganda.
Hahn JA; Maier M; Byakika-Tusiime J; Oyugi JH; Bangsberg DR
J Int Assoc Physicians AIDS Care (Chic); 2007 Jun; 6(2):83-6. PubMed ID: 17537997
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and tolerability of nevirapine- versus efavirenz-containing regimens in HIV-infected Thai children.
Lapphra K; Vanprapar N; Chearskul S; Phongsamart W; Chearskul P; Prasitsuebsai W; Chokephaibulkit K
Int J Infect Dis; 2008 Nov; 12(6):e33-8. PubMed ID: 18573672
[TBL] [Abstract][Full Text] [Related]
39. Risk of nevirapine-associated Stevens-Johnson syndrome among HIV-infected pregnant women: the Medunsa National Pharmacovigilance Centre, 2007 - 2012.
Dube N; Adewusi E; Summers R
S Afr Med J; 2013 May; 103(5):322-5. PubMed ID: 23971123
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis.
Arrivé E; Newell ML; Ekouevi DK; Chaix ML; Thiebaut R; Masquelier B; Leroy V; Perre PV; Rouzioux C; Dabis F;
Int J Epidemiol; 2007 Oct; 36(5):1009-21. PubMed ID: 17533166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
